Hybrid Conferencee

International Conference on Diabetes Treatment and Therapy (ICDTT - 27)

6th - 7th April 2027 | Ordino, Andorra
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Ordino. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Ordino event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Ordino conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Ordino, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Ordino."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Molecular Markers in Diabetes and Metabolic Syndrome

This track will explore the latest research on molecular markers associated with metabolic syndrome and Type 2 diabetes. Emphasis will be placed on the identification and validation of inflammatory markers that can aid in early diagnosis and treatment strategies.

Track 02

Innovations in Pharmacotherapy for Diabetes Management

This session will focus on advancements in pharmacotherapy for diabetes, highlighting new drug treatments and their mechanisms of action. Discussions will include the efficacy and safety profiles of emerging therapies in clinical practice.

Track 03

Technological Advances in Diabetes Treatment Devices

This track will cover the development and implementation of novel devices for diabetes management, including insulin pumps and artificial beta cells. Participants will discuss the impact of these technologies on patient outcomes and quality of life.

Track 04

Closed Loop Systems and Biostator Innovations

This session will delve into the advancements in closed-loop systems for diabetes management, including the Biostator technology. The focus will be on how these systems can improve glycemic control and reduce the burden of diabetes management.

Track 05

Novel Insulin Delivery Techniques and Devices

This track will examine the latest innovations in insulin delivery methods, including the development of insulin pens and other novel techniques. The aim is to enhance patient adherence and optimize glycemic control.

Track 06

Diabetes in Special Populations: Pediatric and Gestational Considerations

This session will address the unique challenges and management strategies for diabetes in pediatric populations and during gestation. Discussions will include the implications of hyperglycemia and diabetes on maternal and child health.

Track 07

Autoimmune and Monogenic Forms of Diabetes

This track will focus on the complexities of autoimmune diabetes mellitus and monogenic forms of diabetes, including neonatal diabetes. Participants will explore genetic underpinnings and potential therapeutic approaches.

Track 08

Prediabetes and Immune Intervention Strategies

This session will investigate the role of immune interventions in the prevention and management of prediabetes. The discussion will include emerging therapies aimed at modulating immune responses to delay or prevent diabetes onset.

Track 09

Clinical Approaches to Diabetes and Its Complications

This track will focus on clinical strategies for managing diabetes and its associated complications. Emphasis will be placed on diagnostic approaches and patient-oriented case management.

Track 10

Advancements in Biomarker Discovery for Diabetes Treatment

This session will highlight recent advancements in the discovery of biomarkers for diabetes treatment. The focus will be on how these biomarkers can inform therapeutic decisions and improve patient outcomes.

Track 11

Regulatory and Economic Aspects of Diabetes Research

This track will explore the regulatory and economic considerations in diabetes research and treatment. Discussions will include the implications of policy changes on research funding and access to innovative therapies.